IFNL2 and infection: In such LKR10-IFNLR1+ cells, IFN-λ2 treatment inhibited VSV and KJ7 (Figure 1D,E, right graphs) infection by more than 95%, while MuHV-4 infection was decreased by 65% (Figure 1F, right).